ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,332,000 | -56.7% | 114,500 | -64.5% | 0.82% | -34.8% |
| Q1 2019 | $3,078,000 | +526.9% | 322,600 | +836.3% | 1.26% | +225.5% |
| Q3 2018 | $491,000 | -55.7% | 34,456 | -62.7% | 0.39% | +27.6% |
| Q2 2018 | $1,109,000 | +123.6% | 92,400 | +129.9% | 0.30% | +340.6% |
| Q1 2018 | $496,000 | -75.6% | 40,200 | -71.2% | 0.07% | -71.7% |
| Q4 2017 | $2,030,000 | -19.3% | 139,500 | -21.1% | 0.24% | -11.3% |
| Q3 2017 | $2,516,000 | +39.8% | 176,800 | +25.3% | 0.28% | +25.6% |
| Q2 2017 | $1,800,000 | -7.5% | 141,100 | -8.0% | 0.22% | -8.8% |
| Q1 2017 | $1,945,000 | +128.8% | 153,400 | +84.2% | 0.24% | +58.9% |
| Q4 2016 | $850,000 | -33.2% | 83,300 | -13.8% | 0.15% | -49.5% |
| Q3 2016 | $1,272,000 | -52.9% | 96,600 | -54.6% | 0.30% | -55.8% |
| Q2 2016 | $2,703,000 | +52.7% | 212,800 | +58.8% | 0.68% | +18.4% |
| Q1 2016 | $1,770,000 | +114.3% | 134,000 | +149.5% | 0.57% | +14.9% |
| Q4 2015 | $826,000 | – | 53,700 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |